Back to search
FDAFDA · Food and drugs·Recall number Z-1481-2024

Hemostasis Probe, Model: CD-B622LA

Published April 17, 2024 · Recall initiated: January 5, 2024

Summary

FDA records medical device Class II recall Z-1481-2024, published April 17, 2024 and initiated January 5, 2024. Recalling firm: Olympus Corporation of the Americas; Status: Ongoing; Reported quantity: 36 units (all OUS); Lot: Model Number: CD-B622LA; UDI/DI: 00821925039452; Lot Number: KR214212. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The BICOAG Hemostasis Probe with a coaxial plug was mispackaged into the package and labeled as a BICOAG Hemostasis Probe with a fixed pin connector.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Olympus Corporation of the Americas
Distributor
International distribution only.
Lot
Model Number: CD-B622LA; UDI/DI: 00821925039452; Lot Number: KR214212
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Hemostasis Probe, Model: CD-B622LA recalled?

Yes. FDA published recall Z-1481-2024 on April 17, 2024. Reported hazard: The BICOAG Hemostasis Probe with a coaxial plug was mispackaged into the package and labeled as a BICOAG Hemostasis Probe with a fixed pin connector.

What should I do if I have this product?

Voluntary: Firm initiated · Letter